Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
qpRNzg8NB6a3e4HB
Listen
